aTyr Pharma Inc. (United States) is listed on the Nasdaq and has a market capitalization of $-, with shareholders equity totaling $476.17 .
The company employs approximately 44 people and operates in the Health Care sector, within the Biotechnology industry.
Over the past 12 months, aTyr Pharma Inc. reported $586.53 in revenue, generating net income of $-106.43 .
Key financial metrics include a P/E ratio of -, a price-to-book (P/B) ratio of -, and a trailing twelve-month dividend yield of -.
The company trades under the ticker LIFE.